Meflon 250 mg tablet is an antimalarial medicine containing mefloquine. It is used to treat acute malaria and to prevent malaria in people travelling to areas where the disease is common. The doctor decides the dose and course.
There are 3 brands of Mefloquine listed in Bangladesh. 2 of them have a lower unit price than Meflon. The lowest listed price is Mef-Q 250 mg Tablet at ৳ 32.00 per unit.
What is Meflon 250 mg Tablet?
Meflon 250 mg tablet is an antimalarial medicine. Its active ingredient is mefloquine. It is used to treat acute malaria caused by certain malaria parasites, including strains that are resistant to chloroquine. It is also used to prevent malaria in people who are travelling to areas where malaria is common. Meflon works by affecting the malaria parasite in the blood. The doctor decides the dose and how long it should be taken. The tablet is available in a pack of 10 x 10. It should be stored in a cool, dry place, away from light.
Uses of Meflon
Meflon is used to treat acute malaria infections caused by Plasmodium falciparum and Plasmodium vivax, including chloroquine-resistant strains of P. falciparum. It is also used to prevent malaria caused by these parasites in people who are at risk, such as travellers to areas where malaria occurs. The doctor decides whether this medicine is suitable and how it should be taken.
How to use Meflon
Meflon 250 mg tablet is taken by mouth. The dose and course are decided by the doctor, who will consider whether it is for treatment or prevention and the person's weight and health. It can be taken with food and a drink of water to reduce stomach upset. Do not change the dose or stop early without medical advice. If a dose is missed, ask the doctor or pharmacist what to do.
Side effects of Meflon
When used to prevent malaria, side effects of mefloquine have included vomiting, dizziness, fainting, and extra heartbeats. When used to treat malaria, common side effects have included dizziness, muscle pain, nausea, fever, headache, vomiting, chills, diarrhoea, skin rash, abdominal pain, tiredness, loss of appetite, and ringing in the ears. Report any unusual symptoms, especially mood changes or heart problems, to a doctor promptly.
Safety and precautions
Meflon is not for everyone. It should not be used by people with a known allergy to mefloquine or related medicines such as quinine and quinidine, or by people with active depression, recent depression, generalised anxiety disorder, psychosis, schizophrenia, or other major psychiatric disorders, or a history of convulsions. It may cause psychiatric symptoms such as anxiety, paranoia, depression, hallucinations, and rarely suicidal thoughts. Caution is needed in people with a history of depression or epilepsy. There are no adequate and well-controlled studies in pregnant women; use in pregnancy only if the doctor decides the benefit justifies the risk. Mefloquine passes into breast milk in small amounts, so the doctor will decide whether to continue breastfeeding. Tell the doctor about all medicines you take before starting Meflon.
Frequently asked questions
Is Meflon safe during pregnancy or breastfeeding?
There are no adequate and well-controlled studies in pregnant women. Meflon should be used during pregnancy only if the doctor decides the benefit justifies the risk. Mefloquine is excreted in breast milk in small amounts, so the doctor will decide whether to continue the medicine or breastfeeding. Always ask the doctor first.
What is Meflon used for and what kind of medicine is it?
Meflon 250 mg tablet is an antimalarial medicine. It is used to treat acute malaria caused by Plasmodium falciparum and Plasmodium vivax, including chloroquine-resistant strains, and to prevent malaria in people at risk. The doctor decides the dose and course.
What does the generic name mefloquine mean?
Mefloquine is the generic name of the active ingredient in Meflon. It belongs to a group of antimalarial medicines that act on the malaria parasite in the blood. The doctor or pharmacist can explain more about how it works.
Acute Malaria Infections caused by Mefloquine-susceptible strains of Plasmodium falciparum (both chloroquine- susceptible and resistant strains) or by P. vivax
Prophylaxis of P. falciparum and P. vivax malaria infections
Pharmacology
Mefloquine has been found to produce swelling of the Plasmodium falciparum food vacuoles. It may act by forming toxic complexes with free heme that damage membranes and interact with other plasmodial components.
Mefloquine is an antimalarial agent which acts as a blood schizonticide. Mefloquine is active against the erythrocytic stages of Plasmodium species. However, the drug has no effect against the exoerythrocytic (hepatic) stages of the parasite. Mefloquine is effective against malaria parasites resistant to chloroquine. Mefloquine is a chiral molecule. According to some research, the (+) enantiomer is more effective in treating malaria, and the (-) enantiomer specifically binds to adenosine receptors in the central nervous system, which may explain some of its psychotropic effects.
Dosage & Administration
Adult:
Malaria prevention: 1 tablet (250 mg) once per week starting 1-2 weeks before departure and continued for 4 weeks after leaving malarious area.
Malaria treatment: 5 tablets (5X250 mg) in a single dose (up to max. 1.5 gm) or preferably in 2 divided doses 6 to 8 hours apart.
In Children 6 Months and Older:
Malaria prevention: Approximately 5 mg/kg body weight once per week (250 mg for children weighing over 45 kg, decreasing in proportion to body weight for children weighing 45 kg or less).
Malaria treatment: 20 to 25 mg/kg body weight which may be split into two doses 6 to 8 hours apart to reduce the occurrence or severity of adverse reactions.
Geriatric Use: Experiences have not identified differences in responses between the elderly and younger patients.
Should be taken with food. Best taken with meals & a full glass of water.
Interaction
Increased risk of ECG abnormalities with quinine or chloroquine, antihistamines, TCAs and phenothiazines. May increase risk of seizure with quinidine or quinine. Concomitant use with valproic acid, phenobarbital, carbamazepine and phenytoin may cause loss of seizure control and lower plasma levels of anticonvulsants. Increased risk of QT prolongation and arrhythmia with ketoconazole. Concomitant use with digoxin, Ca channel blockers, antiarrhythmics and β-blockers may increase the risk of cardiotoxicity. Increased risk of ventricular arrhythmias with amiodarone. Concomitant use with TCAs, SSRIs, buprion, antipsychotic, tramadol may increase the risk of convulsions. Increased plasma levels with metoclopromide. May compromise adequate immunisation by live typhoid vaccine. Vaccinations with attenuated live bacteria should be completed at least 3 days prior the 1st dose of mefloquine.
Contraindications
Use of Mefloquine is contraindicated in patients with a known hypersensitivity to Mefloquine or related compounds (e.g. quinine and quinidine). It should not be prescribed for prophylaxis in patients with active depression, a recent history of depression, generalized anxiety disorder, psychosis, or schizophrenia or other major psychiatric disorders, or with a history of convulsions.
Side Effects
Among subjects who received Mefloquine for prophylaxis of malaria, following side effects was observed:
The most frequently observed sied-effects were vomiting, dizziness, syncope, extrasystoles and other complaints affecting less than 1%. Among subjects who received Mefloquine for treatment, following side-effects was observed:
The most frequently observed side-effects included : dizziness, myalgia, nausea, fever, headache, vomiting, chills, diarrhoea, skin rash, abdominal pain fatigue, loss of appetite, and tinnitus
Pregnancy & Lactation
Use in Pregnancy: There is no adequate and well-controlled study in pregnant women. However, clinical experience with Mefloquine has not revealed an embrytoxic or teratogenic effect. Mefloquine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in Nursing Mothers: Mefloquine is excreted in breast milk in small amounts. the activity of which is unknown. Because of the potential for serious adverse reactions in nursing infants form Mefloquine. a decision should be made whether to discontinue the drug taking into account the importance of the drug to the mother.
Precautions & Warnings
Warnings: Mefloquine may cause psychiatric symptoms in a number of patients, ranging from anxiety, paranoia, and depression to hallucinations and psychotic behavior. Rare cases of suicidal ideation and suicide have been reported though no relationship to drug administration has been confirmed. Mefloquine should be used with caution in patients with a previous history of depression. Concomitant administration of Mefloquine and quinine or quinidine may produce electrocardiographic abnormalities and may increase risk of convulsions.
Precautions: In patients with epilepsy, Mefloquine may increase the risk of convulsions. Caution should be exercised with regard to activities requiring alertness and fine motor coordination such as driving, piloting aircraft and operating machinery. Mefloquine should be used with caution in patients with psychiatric disturbances. In patients with impaired liver function the elimination of Mefloquine may be prolonged, leading to higher plasma levels.
Overdose Effects
In cases of overdosage with Mefloquine, the symptoms may be more pronounced. The following procedure is recommended in case of overdosage:
Induce vomiting or perform gastric lavage, as appropriate.
Monitor cardiac function (if possible by ECG), neurologic and psychiatric status for at least 24 hours.
Provide Symptomatic and intensive supportive treatment as required, particularly of cardiovascular disturbance.
Treat vomiting or diarrhoea with standard fluid therapy.
Storage Conditions
Store in a cool dry place. Protect from light.
Alternative brands of Mefloquine
Other brands with the same generic name, cheapest first.